原发性食道恶性黑色素瘤一例
摘要
<正>病例患者,女,68岁。吞咽梗阻半年余,发现食管占位近3月。2017年12月27日食道钡餐造影提示食道胸上段占位性病变,2018年3月18日胸部CT平扫:食管上段占位(最大径约4.8cm),Ca可能,建议食管镜检查。2018年3月21日胃镜检查:食管距门齿24～18cm见粘膜半环
引文
[1] Goppner D, Ulrich J, Pokrywka A, et al. Sentinel lymph node biopsy status is a key parameter to stratify to stratify the prognostic heterogeneity of malignant melanoma in high-risk tumors>4.0mm[J].Dermatology,2011,222(1):59-66.
[2] Tirumani H, Rosenthal MH, Tirumani SH, et al. Imanging of un-common esophageal malignancies[J].Dis Esophagus,2015,28(6):552-559.
[3] Sanchez AA, Wu TT, Prieto VG, et al. Comparison of primary and metastatic malignant melanoma of the esophagus:clinicopathologic review of 10 cases[J].Arch Pathol Lab Med,2008,132(10):1623-1629.
[4]宋欣,宋晖,李红卫.原发性食管恶性黑色素瘤6例临床分析[J].肿瘤基础与临床,2015,28(6):539-540.
[5] Iwanuma Y, Tomita N, Amano T, et al. Current status of primary malignant melanoma of the esophagus:clinical features,pathology,management and prognosis.J Gastroenterol,2012,47(1):21.
[6] Hasskamp JH,Elias EG, Zapas JL. In vivo effects of sequential granulocyte-macrophage colony stimulating factor(GM-CSF)and interleukin-2(IL-2)on circulating dendritic cells(DC)in patients with surgically resected high risk cutaneous melanoma. J Clin Immunol,2006,26(4):331.
[2] Tirumani H, Rosenthal MH, Tirumani SH, et al. Imanging of un-common esophageal malignancies[J].Dis Esophagus,2015,28(6):552-559.
[3] Sanchez AA, Wu TT, Prieto VG, et al. Comparison of primary and metastatic malignant melanoma of the esophagus:clinicopathologic review of 10 cases[J].Arch Pathol Lab Med,2008,132(10):1623-1629.
[4]宋欣,宋晖,李红卫.原发性食管恶性黑色素瘤6例临床分析[J].肿瘤基础与临床,2015,28(6):539-540.
[5] Iwanuma Y, Tomita N, Amano T, et al. Current status of primary malignant melanoma of the esophagus:clinical features,pathology,management and prognosis.J Gastroenterol,2012,47(1):21.
[6] Hasskamp JH,Elias EG, Zapas JL. In vivo effects of sequential granulocyte-macrophage colony stimulating factor(GM-CSF)and interleukin-2(IL-2)on circulating dendritic cells(DC)in patients with surgically resected high risk cutaneous melanoma. J Clin Immunol,2006,26(4):331.